Compare Nuscale Power Corporation (SMR) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuscale Power Corporation vs Tilray Brands Inc — how do they compare? Nuscale Power Corporation trades at $7.2 (market cap $3.00B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Nuscale Power Corporation is far larger — about 5.7× Tilray Brands Inc's market cap, and Nuscale Power Corporation is more actively traded (43,143,109 versus 9,099,075). Which is the better fit depends on your goals — on Pluang, investors hold Nuscale Power Corporation for 29 Days and Tilray Brands Inc for 31 Days on average.
| SMR | TLRY | |
|---|---|---|
Market Cap | $3.00B | $530.54M |
Volume | 43,143,109 | 9,099,075 |
Sector | Industrials | Health |
52-Week High | $53.43 | $17.20 |
52-Week Low | $7.20 | $3.54 |
Typical Hold Time | 29 Days | 31 Days |
Enterprise Value | $1.93B | $684.46M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NuScale Power (SMR) trades at $7.32, down 4.56% with bearish technical signals. The company shows concerning fundamentals with negative net income margin of -3,888.7% and declining revenue from $31.48M in 2025 to $11M in 2026. Despite operating cash burn, financing activities provided $1.31B in 2025. Analyst consensus is mixed with 50% buy ratings but ongoing SEC investigation concerns.
The stock faces significant execution risk in commercializing SMR technology amid cash burn and competitive pressure. Upside exists if NuScale achieves commercialization milestones, with analyst targets up to $16. However, current financial performance and negative margins present substantial risk for investors seeking near-term returns.
TLRY trades at $3.59, down 3.36% on the day and near 52-week lows, with a bearish technical signal. The company reported revenue of $821.31M for 2025 but posted a net loss of -$2.19B, missing earnings expectations for four consecutive quarters. While analyst consensus shows 70% hold ratings, the stock faces significant profitability challenges with negative margins and cash flow concerns despite some revenue growth projections.
The outlook remains challenging with persistent losses and negative cash flow, though the stock trades at discounted valuation multiples. Key risks include ongoing profitability struggles and cannabis regulatory uncertainty. Potential catalysts include upcoming Q1 2027 earnings on October 8, 2026, and potential marijuana reform developments that could benefit the company's positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
